Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) — Strategic Asset Allocation Index

Latest as of June 2023: 43.1%

Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) has a Strategic Asset Allocation Index of 43.1% as of June 2023. Strategic assets (PP&E of CN¥808.86 Million plus long-term investments of CN¥-) total CN¥808.86 Million, measured against net assets of CN¥1.88 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.

SAAI

43.1%
Strategic Assets / Net Assets

Strategic Assets

CN¥808.86 Million
PP&E + LT Investments

PP&E

CN¥808.86 Million
CNY

Net Assets

CN¥1.88 Billion
CNY

Shanghai Haishun New Pharmaceutical Packaging Co Ltd Strategic Asset Allocation Index (2011–2022)

This chart shows how Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of June 2023, the index stands at 43.1%, representing strategic assets of CN¥808.86 Million against net assets of CN¥1.88 Billion CNY. Explore Shanghai Haishun New Pharmaceutical Pack cash flow conversion to assess how effectively this company generates cash.

Annual Strategic Asset Allocation Index for Shanghai Haishun New Pharmaceutical Packaging Co Ltd (2011–2022)

The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai Haishun New Pharmaceutical Packaging Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Shanghai Haishun New Pharmaceutical Pack (300501) market capitalisation.

Year SAAI Strategic Assets (CNY) PP&E LT Investments Net Assets Change (pp)
2022 44.3% CN¥744.48 Million CN¥744.48 Million CN¥- CN¥1.68 Billion ▲ +1.8 pp
2021 42.5% CN¥674.09 Million CN¥674.09 Million CN¥- CN¥1.59 Billion ▼ -12.4 pp
2020 54.9% CN¥481.29 Million CN¥481.29 Million CN¥- CN¥876.40 Million ▲ +11.1 pp
2019 43.8% CN¥334.18 Million CN¥334.18 Million CN¥- CN¥762.37 Million ▲ +0.6 pp
2018 43.3% CN¥309.29 Million CN¥308.80 Million CN¥482.61K CN¥714.84 Million ▲ +13.7 pp
2017 29.6% CN¥187.56 Million CN¥187.56 Million CN¥- CN¥633.69 Million ▲ +6.4 pp
2016 23.2% CN¥138.10 Million CN¥138.10 Million CN¥- CN¥594.42 Million ▼ -6.0 pp
2015 29.3% CN¥79.32 Million CN¥79.32 Million CN¥- CN¥270.92 Million ▼ -2.6 pp
2014 31.9% CN¥73.96 Million CN¥73.96 Million CN¥- CN¥232.14 Million ▼ -8.8 pp
2013 40.7% CN¥79.66 Million CN¥79.66 Million CN¥- CN¥195.85 Million ▼ -4.1 pp
2012 44.8% CN¥73.88 Million CN¥73.88 Million CN¥- CN¥164.87 Million ▼ -8.3 pp
2011 53.1% CN¥69.51 Million CN¥69.51 Million CN¥- CN¥130.81 Million
pp = percentage points